News

Google VC-backed startup plays 'Moneyball' in Big Pharma partnerships

As large drugmakers embrace collaborations to ease various R&D pains, a software upstart has emerged with analytics that give biotech and pharma leaders insights into how well their external...

Sanofi secures computational help for rare disease research

Sanofi ($SNY) has made another move to tap external partners for new science and technology, this time in a tie-up that enables the French drug giant to benefit from computational approaches to...

What IT services do biopharma execs really want?

In reading a recent report and survey from Booz & Co. on biopharma outsourcing trends, I came across a section at the tail end of the 16-page document that shed some light on the survey...

Pfizer hits recruitment rut for virtual clinical trial

Testing a cheaper way to do clinical research, Pfizer ($PFE) has stumbled in a journey to complete what's been called the first completely virtual clinical trial.

OpGen pockets up to $17M in VC deal

OpGen has struck a deal with investors to haul in as much as $17 million in a Series C round of financing, providing the company with growth capital to bolster sales of its genomic research tools and...

FDA calls out Biochem for IT no-nos

U.S. regulators have slapped Biochem Laboratories with a warning concerning several breaches. However, the one generating lots of buzz appears to be the contract testing lab's practice of letting...

Reuters advances life sciences informatics platform

Thomson Reuters has built APIs to streamline access to its vast amounts of data on drug research and development and business intelligence for biopharma customers, the company said. And it turns out that the APIs or application programming interfaces were influenced by the information giant's work with biotech powerhouse Biogen Idec ($BIIB).

Ex-NCI cancer informatics chief lands at ASU

After NIH advisers found his cancer informatics program lacking in key areas last year, Kenneth Buetow has headed for the desert to take his new job at Arizona State University.

Social media jump-starts stalled patient recruitment efforts

Drug developers have picked up social media and online tools to find patients for clinical trials, realizing benefits beyond just getting qualified participants into their studies. Groups have found other perks such as the ability to stay connected with patients and build a network of people to tap for future recruitment drives.

NIH backs effort to integrate clinical trials data into EHRs

The National Cancer Institute (NCI), which is part of the NIH, is joining forces with Health Level Seven International (HL7) to connect trials data with electronic health records, the group announced last month.

Aptiv marries IT and CRO services to tackle adaptive trials market

Aptiv Solutions has struck another deal to build its technology offerings in support of complex clinical studies with adaptive designs--also known as adaptive clinical trials. The venture-backed...

OmniComm licenses clinical trials software to CRO Pharma Medica

OmniComm Systems has buttressed its claim to being one of the fastest-growing providers of electronic data capture software (EDC) for clinical trials. The Fort Lauderdale, FL-based company has...

Certara snaps up drug research software outfit Simcyp for $32M

Certara has struck a deal to scoop up Simcyp, a maker of modeling software for preclinical drug research, in a move that expands the breath of its technology offerings to drug developers. The deal is...

Algorithm may expose drug targets for Alzheimer's

Protein misfolding has been implicated in many different diseases ranging from certain forms of Lou Gehrig's disease and Alzheimer's to cancer. Now a research group hopes that its algorithm...

Roche getting entire workforce to use Google Apps

Swiss drug giant Roche ($RHHBY) has generated buzz in the tech press for deciding to adopt Google Apps for its more than 90,000 workers, using the cloud-based software as a way to connect its global...

J&J hires Selventa to build computerized models for personalized medicine

Selventa has embarked on a multiyear project to furnish healthcare giant Johnson & Johnson's ($JNJ) Janssen R&D group with disease models, in an effort to understand the mechanisms of...

Startup aims to tap wisdom of the crowd for low-cost drug trials

As drugmakers struggle to control high development costs, a New York-based startup called Transparency Life Sciences has hatched with big plans to drastically lower the cost of drug development with...

Finding the world's smartest biotech techies

I'm calling on the readers of FierceBiotech IT to help me identify the world's best biotech techies. As you read here every week, biotech stakeholders have digitized their work in ways that...

Big Pharma activity eyed in mobile trends

The life sciences industry could drive at least a couple trends this year in the mobile tech arena, according to mobihealthnews. In a roundup of a dozen trends to watch this year, the publication...

Google software could aid drug design

Chemists have tapped core Google ($GOOG) software for measuring the importance of web pages to study the shape and organization of molecules. The researchers' adapted version of Google's...